Pfizer (NEOE:PFE) Accounts Payable : C$7,523 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Pfizer Accounts Payable?

Pfizer's Accounts Payable for the quarter that ended in Mar. 2025 was C$7,523 Mil.

Pfizer's quarterly Accounts Payable increased from Sep. 2024 (C$7,198 Mil) to Dec. 2024 (C$8,025 Mil) but then declined from Dec. 2024 (C$8,025 Mil) to Mar. 2025 (C$7,523 Mil).

Pfizer's annual Accounts Payable declined from Dec. 2022 (C$9,250 Mil) to Dec. 2023 (C$9,002 Mil) and declined from Dec. 2023 (C$9,002 Mil) to Dec. 2024 (C$8,025 Mil).

Pfizer Accounts Payable Historical Data

The historical data trend for Pfizer's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Accounts Payable Chart

Pfizer Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable

Get a 7-Day Free Trial

5,486.10

7,139.84

9,250.03

9,002.14

8,025.34

Pfizer Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable	Get a 7-Day Free Trial															7,567.98	6,997.77	7,198.34	8,025.34	7,522.54

Pfizer Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Pfizer Accounts Payable Related Terms

Thank you for viewing the detailed overview of Pfizer's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Pfizer Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (NEOE:PFE) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

PFE:USA PFE:Peru PFE:Mexico PFE_KZ:Kazakhstan 1PFE:Italy PFEd:UK 0Q1N:UK PFEB:Germany PFE:Germany PFE:Germany PFE:Germany PFE:Germany PFIZ34:Brazil PFE:Bulgaria PFE:Austria PFE:Argentina

Address

66 Hudson Boulevard East, New York, NY, USA, 10001-2192

Website

https://www.pfizer.com

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.